Genomics is transforming healthcare by making it more targeted, personalized and proactive. However, bringing genome-enabled health care to citizens across the U.S. and beyond remains a challenge—mostly due to insurance barriers, a broad lack of clinical understanding, and the sheer volume and complexity of new tests being brought to market.
This week’s “The Next Wave,” features host Young Sohn talking to Lisa Alderson, CEO of Genome Medical, about her plans to make genomics more accessible for everyone. They also discuss the ethical questions raised by genomics, as well as the critical role this game-changing technology played in developing Covid vaccines in record time.